• Public Health Programs

• 64.

United Pompe Foundation

SUPPORT RESEARCH FOR POMPE DISEASE AND HELP PATIENTS DEALING WITH POMPE DISEASE United Pompe Foundation The United Pompe Foundation was formed to assist patients andor their families with medical costs and other expenses that these patents and families face and may not be able to cover or fully cover through their insurance.

• Arthritis

• 65.

Arthritis Foundation Inc

Here for the 1 in 4 with #arthritis. | Fighting to cure the #1 cause of disability.

Rheumatology Research Foundation

Advancing research and training to improve the health of people with rheumatic diseases.

Lupus Foundation of America, Inc.

Lupus Foundation of America is the only national force devoted to solving the mystery of lupus while giving support to those who suffer from its brutal impact.

• Birth Defects, Genetic Diseases Research

• 68.

International Association for Chronic Fatigue Syndrome-Me

THE MISSION OF IACFS/ME IS TO PROMOTE, STIMULATE AND COORDINATE THE EXCHANGE OF IDEAS RELATED TO CHRONIC FATIGUE SYNDRONE(CFS) AND FIBROMYALGIA(FM) RESEARCH, PATIENT CARE AND TREATMENT IN ADDITION, THE IACFS/ME PERIODICALLY REVIEWS THE CURRENT RESEARCH AND TREATMENT LITERATURE AND MEDIA REPORTS FOR THE BENEFIT OF SCIENTISTS, CLINICIANS AND PATIENTS.

DIABETES SOLUTIONS OK INC

We are a nonprofit dedicated to bettering the lives of those affected by type 1 diabetes.

• International Relief

• 70.

Childhood Diabetes Research Institute

The Organization supports programs, clinics and hospitals that educate the public, provide therapies, medical equipment and supplies that treat diabetes and other degenerative diseases.

• Medical Specialty Research

• 71.

THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

A nonprofit institute, translating genomic research into life changing results.

• Health (General and Financing)

• 72.

T1D EXCHANGE INC

T1D Exchange is a nonprofit dedicated to improving outcomes for the entire T1D population through driving real-world evidence and collaborative change.